Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

By A. Schweitzer, J. Horn, R. Mikolajczyk, G. Krause, J. J. Ott. The Lancet, 2015

2,503 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/140960af45fcfff2e5a00fbeeb5b2f53b047dae3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Zoulim
2. K. Agarwal
3. H. Janssen
4. P. Lampertico

Citations in the corpus

• EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (2017, background): “Approximately 240 million people are chronic HBV surface antigen (HBsAg) carriers, with a large regional variation of HBsAgpositive patients between low (\2%) and high ([8%) endemicity levels.(2,4) The prevalence is decreasing in several highly endemic countries due to improvements in the socioecono”
• Global Cancer in Women: Burden and Trends (2017, unknown): “S20;ref.149).”